Topics

Astellas, Adaptimmune to work on T-cell therapies

05:27 EST 16 Jan 2020 | SmartBrief

Astellas and Adaptimmune have partnered to develop T-cell receptor and allogeneic chimeric antigen receptor T-cell therapies. -More

Original Article: Astellas, Adaptimmune to work on T-cell therapies

NEXT ARTICLE

More From BioPortfolio on "Astellas, Adaptimmune to work on T-cell therapies"

Quick Search